Lace up your corset or dust off a bowler hat and prepare to step back into the shadowy streets of Victorian London—Miss Scarlet is returning to MASTERPIECE Mystery! Read on for the latest on the ...

Five years after launching one of the most promising generative biology drug discovery companies, Generate Biomedicines, venture capital powerhouse Flagship Pioneering has brought a generative ...

Dianthus Therapeutics is offering Nanjing Leads Biolabs up to $1 billion biobucks for licensing rights to a bispecific antibody designed to treat certain autoimmune disorders. Under the terms of the ...

A new startup launched out of stealth Thursday to help health systems purchase the best value artificial intelligence for their patients and solve the persistent issue of commercialization for AI ...

Week 7 of the NFL season is underway, and there are some key players dealing with injuries. Los Angeles Rams superstar wide receiver Puka Nacua will miss his first game of the season with an ankle ...

Tropical Storm Melissa lumbered through the Caribbean Sea on Thursday, bringing a risk of dangerous landslides and life-threatening flooding to Jamaica and southern Hispaniola — an island shared by ...

LAS VEGAS—Hinge Health and Omada Health were the first two digital health companies to go public this year after an IPO drought, and the industry has been counting on them to open the floodgates. The ...

Halozyme Therapeutics has been busy. While fighting a patent dispute with Merck & Co. and navigating the impact of the Inflation Reduction Act (IRA), the company has penned an acquisition of fellow ...

A federal judge had previously dismissed the complaint as unnecessarily lengthy and digressive. The president claims that The Times sought to defame him during the 2024 election. By Michael M.

Independent news. Trusted by Texans. About The Texas Tribune | Staff | Contact | Send a Confidential Tip | Ethics | Republish Our Work | Jobs | Awards | Corrections | Strategic Plan | Downloads | ...